Incyte Capex To Revenue from 2010 to 2024

INCY Stock  USD 73.52  1.80  2.51%   
Incyte Capex To Revenue yearly trend continues to be fairly stable with very little volatility. Capex To Revenue will likely drop to 0.01 in 2024. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.01284916
Current Value
0.0122
Quarterly Volatility
0.33461752
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Incyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.8 M, Interest Expense of 2.4 M or Total Revenue of 3.9 B, as well as many indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 2.84. Incyte financial statements analysis is a perfect complement when working with Incyte Valuation or Volatility modules.
  
Check out the analysis of Incyte Correlation against competitors.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Latest Incyte's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Incyte over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Incyte's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incyte's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

Incyte Capex To Revenue Regression Statistics

Arithmetic Mean0.13
Geometric Mean0.04
Coefficient Of Variation261.52
Mean Deviation0.16
Median0.04
Standard Deviation0.33
Sample Variance0.11
Range1.3238
R-Value(0.44)
Mean Square Error0.1
R-Squared0.19
Significance0.10
Slope(0.03)
Total Sum of Squares1.57

Incyte Capex To Revenue History

2024 0.0122
2023 0.0128
2022 0.0229
2021 0.0606
2020 0.0703
2019 0.0362
2018 0.039

About Incyte Financial Statements

Incyte investors use historical fundamental indicators, such as Incyte's Capex To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Incyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Revenue 0.01  0.01 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Incyte Stock Analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.